- Inserts transformed and cleansed data from Bronze into Silver tables.
A practical guide to building persistent AI agent memory with structured Markdown, Obsidian, and bash scripts - Qu4ntking/ai-memory-guide ...
The New Jersey–based company SVE owns the Yenko trademark, and this isn't the first time the historic name has appeared on a mid-engine Corvette with four-figure horsepower. SVE The tuner took apart ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Chevrolet offers up to $10,000 off the 2026 Equinox EV this month, making it almost as affordable as the 2027 Bolt. The 2026 Chevrolet Equinox EV receives discounts up to $10,000 this month. Price ...
The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...
The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...
Cigna Corp's Express Scripts has settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at ...
The Federal Trade Commission and Cigna's Evernorth unit have officially reached a settlement that resolves allegations that the company's pharmacy benefit manager artificially drove up prices for ...
The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices. By Rebecca Robbins and Reed Abelson The reporters have ...
The Federal Trade Commission has agreed to what it called a “landmark” settlement with Express Scripts, allowing the company to bow out of the agency’s lawsuit against major pharmacy benefit managers ...
Broader formulary inclusion of lower-priced drugs and standardized $25/month insulin caps are designed to mitigate rebate-driven selection and reduce patient cost exposure to pre-rebate prices. Lowest ...